Mayo Clinic uses AI stethoscope to detect pregnancy-related heart failure

An AI-enabled stethoscope identified heart failure in two times as many pregnant patients when compared to traditional screening, according to a study published Sept. 2 in Nature Medicine.

Advertisement

Rochester, Minn.-based Mayo Clinic researchers conducted a study of 1,195 pregnant patients at six hospitals in Nigeria. Nigerian women experience pregnancy-related heart failure more than anywhere in the world, according to a Sept. 3 news release from Mayo Clinic. 

Of the 1,195 patients, 587 were screened with the AI-enabled stethoscope and 608 were screened with usual methods between August 2022 and September 2023, with follow-up occurring through May. 

Twice as many pregnancy-related heart conditions, with the potential for heart failure, were detected with the AI-enabled stethoscope, according to the study. 

The findings of the study were presented at the European Society of Cardiology Congress. Read about four of the latest cardiology care guideline updates presented at the congress here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.